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We present a rare case of a patient who presented with acute abdominal pain with a previous history of alpha-1-antitrypsin
deficiency (1-antitrypsin deficiency). Further clinical deterioration necessitated computed tomography (CT) imaging,
which demonstrated a hemoperitoneum. Angiography confirmed the rupture of multiple aneurysms originating from the
mesenteric arterial arcade, which were treated successfully with endovascular embolization. The association between
mesenteric arterial aneurysm rupture and -1-antitrypsin deficiency is explored. (J Vasc Surg 2010;52:467-70.)Visceral artery aneurysms (VAAs) are rare with a true
prevalence difficult to determine because of asymptomatic
patients. However, several autopsy-based studies have re-
ported prevalence rates of 1 in 12,000 to 19,000, with
aneurysms of the superior (SMA) and inferior (IMA) mes-
enteric artery accounting for 5.5% and 1% of cases, respec-
tively.1,2 Synchronous SMA and IMA aneurysmal disease is
exceptionally rare.3 We report a patient with a history of
1-antitrypsin deficiency (AAT), who presented with a
ruptured SMA aneurysm and who was found to have syn-
chronous SMA and IMA aneurysms.
CASE REPORT
A 61-year-old man presented with a 5-day history of increas-
ing lower abdominal pain in July 2009. He had chronic obstructive
pulmonary disease which had necessitated 12 hospital admissions
in the preceding 6 years during which he was also managed
symptomatically for AAT (phenotypically homozygous-PiZZ). He
had a history of hypertension and life-long warfarin therapy for
recurrent pulmonary emboli.
In 2004, he presented with acute abdominal pain. Computer-
ized tomography (CT) imaging demonstrated a large hemoperito-
neum, which necessitated two laparotomies for evacuation of an
intra-peritoneal hematoma followed by ligation of bleeding vessels
in the gastrocolic omentum. He had a further admission in 2005,
with acute abdominal pain, where a CT scan revealed a ruptured
appendiceal abscess which resulted in necrosis of the cecum and
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doi:10.1016/j.jvs.2010.02.291proximal ascending colon. He required a right hemicolectomy
followed by a defunctioning end-ileostomy because of an anasto-
motic leak. He had no previous history or other risk factors for
ischemic heart disease, cerebro- or peripheral vascular disease. He
was a nonsmoker.
On admission, he was hemodynamically stable. His abdomen
was soft but mildly tender across the lower quadrants. His ileos-
tomy was healthy and functioning normally. His hemoglobin was
11.1g/dL and international normalized ratio was 2.9. All other
hematologic analyses were normal. A CT scan revealed a small
amount of free fluid in the peritoneum and retro-peritoneum
without any evidence of hematoma or active bleeding. He was
treated conservatively and his warfarin therapy was discontinued.
However, he became acutely unwell 3 days later with a marked
increase in abdominal pain. His pulse rate was 136/min and blood
pressure was 83/52 mmHg. His peripheries were cold and clammy.
His hemoglobin level had dropped to 7.5 g/dL. Following fluid
resuscitation, an emergency CT scan demonstrated an increase in free
peritoneal fluid with a large right-sided hematoma and active extra-
vasation of contrast from an SMA aneurysm rather than a contained
rupture with contrast in the mesentery (Figs 1 and 2).
An emergency transfemoral mesenteric angiogram confirmed
two ruptured aneurysms of the proximal jejunal branches of the
SMA (Fig 3). Further imaging revealed another 3 IMA aneurysms
remote to the position of the mesenteric hematoma (Fig 4).
Endovascular coil embolization was performed to the proximal
aneurysm of the SMA with 3 Cook magnetic resonance imaging
(MRI) platinum microcoils (William Cook, Europe) (Fig 5). To
preserve the vascular supply to the colon, and as there did not
appear to be active bleeding, coil embolization was not performed
to the IMA aneurysms.
The patient was transferred to the high dependency unit
where he was transfused with 4 units of packed red blood cells. He
returned to the ward 3 days later, where his abdominal pain
gradually subsided. He was discharged on day 14. Unfortunately,
he was readmitted 4 months later with acute abdominal pain. CT
imaging revealed no evidence of recurrent bleeding and he settled
with conservative treatment.
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VAAs remain rare and potentially lethal, with nearly
22% presenting as emergencies after rupture. Depending
on the anatomical location, mortality rates range from 20%
to 70%.1 Pathophysiology usually involves saccular or fusi-
form macroaneurysms secondary to elastic fiber fragmenta-
tion, loss of smooth muscle, and internal elastic lamina
disruption resulting in wall weakness with nonhemolytic
streptococcal infections relating to left-sided endocarditis,
accounting for 58% to 63% of all SMA aneurysms. How-
ever, recent reports suggest an infective etiology in less than
30%, with atherosclerosis accounting for 25% of cases,
whereas hepatopancreatobiliary inflammatory processes oc-
cur in 12% of such aneurysms.3 Other rarer associations
include connective tissue disorders, Behçet syndrome, cys-
tic medial necrosis, neurofibromatosis, and trauma, which
result in a “field change” as 30% of patients will have
multiple aneurysms.4
The -1-antitrypsin molecule, controlled by a pair of
genes at the protease inhibitor (Pi) locus, acts to inhibit the
activities of neutrophil-derived proteases, including trypsin,
which, if left unchecked, can damage healthy tissue. The
gene is highly pleomorphic and identified in 1 of 3000 to
5000 individuals. The first association between AAT and
aneurysms described an “in vitro collagenolysis” as the
patho-etiological mechanism for abdominal aortic aneurys-
mal (AAA) disease.5
To our knowledge, this is only the second reported case
Fig 1. Axial computed tomography (CT) image showing high
attenuation point in the region of superior mesenteric artery
(SMA) consistent with active extravasation of contrast (white ar-
row) with adjacent hematoma (black arrow). There is additional
free fluid present on the right side with radiological density con-
sistent with blood (F).to explore the possible association between mesentericartery aneurysms and AAT. The presence of multiple small
aneurysms accentuated both the rarity and diagnostic chal-
lenge associated with our case. The first association be-
tween AAT and VAA, reported by Mitchell et al6 (1993),
described a middle colic artery aneurysm in a patient who
was serologically 1-antitrypsin deficient. This patient suf-
fered an initial ruptured middle colic artery aneurysm fol-
lowed by the development of additional multiple VAAs
during subsequent follow-up imaging. To date, compari-
son with other cases remains difficult.
Schardey et al7 (1998) further reported a higher fre-
quency of AAT phenotypes in 126 patients with AAA
compared to the general population. However, St Jean et
al8 (1996) identified no significant association between
patients with the deficiency alleles compared with the gen-
eral population in 245 patients with aortic or intracranial
aneurysms. Elzouki et al9 (1999) also reported no differ-
ence in AAA prevalence from analysis of 102 consecutive
AAT positive and negative patients.
Schievink et al10 (1996) reported an odds ratio of 2.69
for intracerebral artery aneurysms in patients with AAT
compared with normal controls. Although splenic artery
aneurysms are also associated with AAT, it seems to be a
Fig 2. Sagittal computed tomography (CT) image demonstrat-
ing active contrast extravasation from the largest superior mesen-
teric artery (SMA) aneurysm (white arrow) with the associated
hematoma (black arrow). There is additional free fluid present on
the right side with radiological density consistent with blood (F).secondary phenomenon to liver cirrhosis and portal vein
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an increased protease activity and subsequent proteolytic
damage to the median layer of arterial walls leading to
susceptibility for aneurysmal formation.
Diagnosis of VAA remains difficult. In this case, CT
Fig 3. Transfemoral mesenteric angiography confirmingmultiple
aneurysms of both the superior mesenteric artery (SMA; white
arrows) and inferior mesenteric artery (IMA; black arrow; 5 aneu-
rysms in total).
Fig 4. Transfemoral mesenteric angiography confirmingmultiple
aneurysms of both the superior mesenteric artery (SMA; white
arrows) and inferior mesenteric artery (IMA; black arrows; 5 aneu-
rysms in total).imaging identified active SMA contrast extravasation. Di-agnostically, conventional angiography remains the gold
standard especially in the unstable patient, in whom thera-
peutic modalities such as coil embolization may be per-
formed. However, in the absence of competent angio-
graphic imaging capability, magnetic resonance or CT
angiography can provide high-quality images to facilitate
surgical management planning.
Several studies have reported successful conservative
management of small asymptomatic aneurysms.12 Rupture
remains the most important factor for determination of
both therapeutic intervention and patient outcome where
the rupture rate rises significantly when the aneurysm size
doubles.13 Modern therapeutic strategies include endovas-
cular ablative or stent graft techniques, ligation  aneurys-
mal excision, aneurysmorrhaphy  revascularization, or
mesenteric arterial bypass. Prior to any intervention, it is
essential to determine collateral supply, aneurysm size, and
anatomic position.
As described in this case, endovascular coil emboliza-
tion may be performed using platinum coils or chemical
embolic agents such as ethylene-vinyl alcohol, which re-
duces perioperative mortality and morbidity with success
rates of 90% comparable to open surgery.14 Endovascular
treatment of VAA may also include the use of N-butyl-2-
cyanoacrylate (a medical glue), which, in selective cases of
persistent flow or multiple branch involvement, has been
shown to be a reliable therapeutic option. Failure of endo-
vascular therapy from persistent perfusion has a reported
50% success rate with repeat endovascular embolization.15
Conventional operative management of ruptured VAAs
may still be required in which open ligation and resection of
Fig 5. Transfemoral mesenteric angiography confirming emboli-
zation of the proximal superior mesenteric artery (SMA) aneurysm
with 3 platinum micro-coils (white arrow).the aneurysm can be accompanied by arterial revasculariza-
JOURNAL OF VASCULAR SURGERY
August 2010470 Gordon et altion. Indications for open aneurysmorrhaphy or ligation
with a revascularizing graft are determined by the assess-
ment of bowel viability at the time of surgery. End organ
resection is warranted in the presence of nonviable bowel
secondary to insufficient marginal or collateral blood sup-
ply. Elective repairs are associated with mortality rates of
less than 0.5%, whereas ruptured VAAs are associated with
mortality rates approaching 25%.
CONCLUSION
This case reports the successful endovascular manage-
ment of multiple ruptured SMA aneurysms with adjacent
IMA aneurysms in a patient with previous intra-abdominal
vascular complications and AAT. We recommend contrast-
enhanced CT imaging followed by urgent endovascular coli
embolization. Surgical intervention is required in patients
with widespread collateralization or in larger aneurysms in
whom endovascular ablation has been unsuccessful.
Written informed patient consent was obtained from
the patient for the publication of this study.
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